Treatment of advanced nonsmall cell lung cancer: First line, maintenance and second line – Indian consensus statement update

The management of advanced nonsmall cell lung cancer (NSCLC) patients is becoming increasingly complex with the identification of driver mutations/rearrangements and development/availability of appropriate targeted therapies. In 2017, an expert group of medical oncologists with expertise in treating...

Descripción completa

Detalles Bibliográficos
Autor principal: Prabhash, Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348782/
https://www.ncbi.nlm.nih.gov/pubmed/30766843
http://dx.doi.org/10.4103/sajc.sajc_227_18
_version_ 1783390165303033856
author Prabhash, Kumar
author_facet Prabhash, Kumar
author_sort Prabhash, Kumar
collection PubMed
description The management of advanced nonsmall cell lung cancer (NSCLC) patients is becoming increasingly complex with the identification of driver mutations/rearrangements and development/availability of appropriate targeted therapies. In 2017, an expert group of medical oncologists with expertise in treating lung cancer used data from published literature and experience to arrive at practical consensus recommendations on treatment of advanced NSCLC for use by the community oncologists. This was published subsequently in the Indian Journal of Cancer with a plan to be updated annually. The present document is an update to the 2017 document.
format Online
Article
Text
id pubmed-6348782
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-63487822019-02-14 Treatment of advanced nonsmall cell lung cancer: First line, maintenance and second line – Indian consensus statement update Prabhash, Kumar South Asian J Cancer Review Article The management of advanced nonsmall cell lung cancer (NSCLC) patients is becoming increasingly complex with the identification of driver mutations/rearrangements and development/availability of appropriate targeted therapies. In 2017, an expert group of medical oncologists with expertise in treating lung cancer used data from published literature and experience to arrive at practical consensus recommendations on treatment of advanced NSCLC for use by the community oncologists. This was published subsequently in the Indian Journal of Cancer with a plan to be updated annually. The present document is an update to the 2017 document. Medknow Publications & Media Pvt Ltd 2019 /pmc/articles/PMC6348782/ /pubmed/30766843 http://dx.doi.org/10.4103/sajc.sajc_227_18 Text en Copyright: © 2019 The South Asian Journal of Cancer http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Review Article
Prabhash, Kumar
Treatment of advanced nonsmall cell lung cancer: First line, maintenance and second line – Indian consensus statement update
title Treatment of advanced nonsmall cell lung cancer: First line, maintenance and second line – Indian consensus statement update
title_full Treatment of advanced nonsmall cell lung cancer: First line, maintenance and second line – Indian consensus statement update
title_fullStr Treatment of advanced nonsmall cell lung cancer: First line, maintenance and second line – Indian consensus statement update
title_full_unstemmed Treatment of advanced nonsmall cell lung cancer: First line, maintenance and second line – Indian consensus statement update
title_short Treatment of advanced nonsmall cell lung cancer: First line, maintenance and second line – Indian consensus statement update
title_sort treatment of advanced nonsmall cell lung cancer: first line, maintenance and second line – indian consensus statement update
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348782/
https://www.ncbi.nlm.nih.gov/pubmed/30766843
http://dx.doi.org/10.4103/sajc.sajc_227_18
work_keys_str_mv AT prabhashkumar treatmentofadvancednonsmallcelllungcancerfirstlinemaintenanceandsecondlineindianconsensusstatementupdate

Ejemplares similares